J. Berry

Doxorubicin Conjugation to Reovirus Improves Oncolytic Efficacy in Triple-Negative Breast Cancer

Bernardo A. Mainou, J. Berry, Luis E Munoz, 2020, Molecular therapy oncolytics.

Influenza Virus-like Particle-Based Hybrid Vaccine Containing RBD Induces Immunity against Influenza and SARS-CoV-2 Viruses

Kristen M. Jacobsen, Noopur Bhatnagar, Ki-hye Kim, 2022, bioRxiv.

Local SARS-CoV-2 peptide-specific Immune Responses in Convalescent and Uninfected Human Lung Tissue Models

V. Thannickal, J. Berry, K. Harrod, 2021, medRxiv.

Comprehensive preclinical evaluation of human-derived anti-poly-GA antibodies in cellular and animal models of C9ORF72 disease

L. Petrucelli, R. Nitsch, C. Hock, 2022, bioRxiv.

Current understanding of reovirus oncolysis mechanisms

Bernardo A. Mainou, J. Berry, K. Boehme, 2018, Oncolytic virotherapy.

Enhanced Killing of Triple-Negative Breast Cancer Cells by Reassortant Reovirus and Topoisomerase Inhibitors

Bernardo A. Mainou, G. Tharp, S. Bosinger, 2019, Journal of Virology.

Noncanonical Cell Death Induction by Reassortant Reovirus

Bernardo A. Mainou, G. Joshi, J. Berry, 2020, Journal of Virology.

Non-canonical cell death by reassortant reovirus

Bernardo A. Mainou, J. Berry, V. Raghuram, 2020, bioRxiv.